These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3377837)

  • 1. Reaction of CC-1065 and select synthetic analogs with DNA.
    Hurley LH; Lee CS; McGovren JP; Warpehoski MA; Mitchell MA; Kelly RC; Aristoff PA
    Biochem Pharmacol; 1988 May; 37(9):1795-6. PubMed ID: 3377837
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of CC-1065 to poly- and oligonucleotides.
    Krueger WC; Li LH; Moscowitz A; Prairie MD; Petzold G; Swenson DH
    Biopolymers; 1985 Aug; 24(8):1549-72. PubMed ID: 4041550
    [No Abstract]   [Full Text] [Related]  

  • 3. Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity.
    Hurley LH; Reynolds VL; Swenson DH; Petzold GL; Scahill TA
    Science; 1984 Nov; 226(4676):843-4. PubMed ID: 6494915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for sequence-specific DNA alkylation by CC-1065.
    Hurley LH; Lee CS; McGovren JP; Warpehoski MA; Mitchell MA; Kelly RC; Aristoff PA
    Biochemistry; 1988 May; 27(10):3886-92. PubMed ID: 3408734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of CC-1065 (NSC-298223), a new antitumor antibiotic.
    Martin DG; Chidester CG; Duchamp DJ; Mizsak SA
    J Antibiot (Tokyo); 1980 Aug; 33(8):902-3. PubMed ID: 7429992
    [No Abstract]   [Full Text] [Related]  

  • 6. The chemistry, mechanism of action and biological properties of CC-1065, a potent antitumor antibiotic.
    Reynolds VL; McGovren JP; Hurley LH
    J Antibiot (Tokyo); 1986 Mar; 39(3):319-34. PubMed ID: 3516958
    [No Abstract]   [Full Text] [Related]  

  • 7. CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.
    Boger DL; Johnson DS
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3642-9. PubMed ID: 7731958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An NMR study of the covalent and noncovalent interactions of CC-1065 and DNA.
    Scahill TA; Jensen RM; Swenson DH; Hatzenbuhler NT; Petzold G; Wierenga W; Brahme ND
    Biochemistry; 1990 Mar; 29(11):2852-60. PubMed ID: 2346749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential antitumor agents. I. Synthesis of pyrroloindazole derivatives related to the pyrroloindole moieties of the antitumor antibiotic CC-1065.
    Massa S; Stefancich G; Artico M; Corelli F; Silvestri R
    Farmaco Sci; 1987 Aug; 42(8):567-74. PubMed ID: 3666127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of T4 DNA ligase activity by (+)-CC-1065: demonstration of the importance of the stiffening and winding effects of (+)-CC-1065 on DNA.
    Sun D; Hurley LH
    Anticancer Drug Des; 1992 Feb; 7(1):15-36. PubMed ID: 1543525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity.
    Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Cozzi P; Geroni C; Mongelli N
    Farmaco; 1997 Dec; 52(12):711-6. PubMed ID: 9648274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity.
    Reynolds VL; Molineux IJ; Kaplan DJ; Swenson DH; Hurley LH
    Biochemistry; 1985 Oct; 24(22):6228-37. PubMed ID: 3002434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA interstrand cross-linking, DNA sequence specificity, and induced conformational changes produced by a dimeric analog of (+)-CC-1065.
    Ding ZM; Hurley LH
    Anticancer Drug Des; 1991 Nov; 6(5):427-52. PubMed ID: 1662513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical study of the sequence specificity in the covalent binding of the antitumor drug CC-1065 to DNA.
    Zakrzewska K; Randrianarivelo M; Pullman B
    Nucleic Acids Res; 1987 Jul; 15(14):5775-85. PubMed ID: 3615201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of the antitumor antibiotic CC-1065 and its analogues in mammalian (V79) cells and bacteria.
    Harbach PR; Zimmer DM; Mazurek JH; Bhuyan BK
    Cancer Res; 1988 Jan; 48(1):32-6. PubMed ID: 3334998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of a pronounced effect of noncovalent binding selectivity on the (+)-CC-1065 DNA alkylation and identification of the pharmacophore of the alkylation subunit.
    Boger DL; Zarrinmayeh H; Munk SA; Kitos PA; Suntornwat O
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1431-5. PubMed ID: 1847523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and characterization of a site-directed CC-1065-N3-adenine adduct within a 117 base pair DNA restriction fragment.
    Needham-VanDevanter DR; Hurley LH
    Biochemistry; 1986 Dec; 25(26):8430-6. PubMed ID: 3030397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of interaction of CC-1065 (NSC 298223) with DNA.
    Swenson DH; Li LH; Hurley LH; Rokem JS; Petzold GL; Dayton BD; Wallace TL; Lin AH; Krueger WC
    Cancer Res; 1982 Jul; 42(7):2821-8. PubMed ID: 7083173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of the antibiotic formed by a Str. canulus 106/78 culture with antibiotic CC-1065].
    Frolova VI; Kuzovkov AD; Chernyshev AI; Taĭg MM; Ivanitskaia LP
    Antibiotiki; 1982; 27(7):483-7. PubMed ID: 7137972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC-1065 analogues bearing different DNA-binding subunits: synthesis, antitumor activity, and preliminary toxicity study.
    Wang Y; Li L; Ye W; Tian Z; Jiang W; Wang H; Wright SC; Larrick JW
    J Med Chem; 2003 Feb; 46(4):634-7. PubMed ID: 12570384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.